159 related articles for article (PubMed ID: 32280469)
1. Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience.
Vozzo CF; Singh T; Bullen J; Sarvepalli S; McCullough A; Kapoor B
Gastroenterol Rep (Oxf); 2020 Apr; 8(2):98-103. PubMed ID: 32280469
[TBL] [Abstract][Full Text] [Related]
2. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
Young S; Rostambeigi N; Golzarian J; Lim N
AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
[No Abstract] [Full Text] [Related]
3. Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.
Khan A; Maheshwari S; Gupta K; Naseem K; Chowdry M; Singh S
J Gastroenterol Hepatol; 2021 Mar; 36(3):775-781. PubMed ID: 32710679
[TBL] [Abstract][Full Text] [Related]
4. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts.
Bercu ZL; Fischman AM; Kim E; Nowakowski FS; Patel RS; Schiano TD; Chang CY; Lookstein RA
AJR Am J Roentgenol; 2015 Mar; 204(3):654-61. PubMed ID: 25714299
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
[No Abstract] [Full Text] [Related]
6. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
7. Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement.
Rowley MW; Choi M; Chen S; Hirsch K; Seetharam AB
J Clin Exp Hepatol; 2018 Sep; 8(3):256-261. PubMed ID: 30302042
[TBL] [Abstract][Full Text] [Related]
8. Added Value of Covered Stents in Transjugular Intrahepatic Portosystemic Shunt: A Large Single-Center Experience.
Gupta AC; Wang W; Shah C; Sands MJ; Bullen J; Remer EM; Bayona PM; Carey W; Kapoor B
Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1723-1731. PubMed ID: 28512687
[TBL] [Abstract][Full Text] [Related]
9. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
[TBL] [Abstract][Full Text] [Related]
14. Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.
Ghannam JS; Cline MR; Hage AN; Chick JFB; Srinivasa RN; Dasika NL; Srinivasa RN; Gemmete JJ
Pediatr Radiol; 2019 Jan; 49(1):128-135. PubMed ID: 30291382
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
16. MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement.
Krishnan A; Woreta TA; Vaidya D; Liu Y; Hamilton JP; Hong K; Dadabhai A; Ma M
J Clin Transl Hepatol; 2023 Feb; 11(1):38-44. PubMed ID: 36406309
[TBL] [Abstract][Full Text] [Related]
17. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
[TBL] [Abstract][Full Text] [Related]
18. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
20. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
